ZA963950B - Heterocyclic spiro compounds, process for the preparation thereof, and pharmaceutical compositions containing them - Google Patents
Heterocyclic spiro compounds, process for the preparation thereof, and pharmaceutical compositions containing themInfo
- Publication number
- ZA963950B ZA963950B ZA963950A ZA963950A ZA963950B ZA 963950 B ZA963950 B ZA 963950B ZA 963950 A ZA963950 A ZA 963950A ZA 963950 A ZA963950 A ZA 963950A ZA 963950 B ZA963950 B ZA 963950B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- substd
- opt
- alkoxy
- halo
- Prior art date
Links
- -1 Heterocyclic spiro compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9505833A FR2734265B1 (fr) | 1995-05-17 | 1995-05-17 | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA963950B true ZA963950B (en) | 1996-11-25 |
Family
ID=9479065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA963950A ZA963950B (en) | 1995-05-17 | 1996-05-17 | Heterocyclic spiro compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
Country Status (15)
Country | Link |
---|---|
US (1) | US5698567A (da) |
EP (1) | EP0743312B1 (da) |
JP (1) | JPH08311067A (da) |
CN (1) | CN1058014C (da) |
AT (1) | ATE186729T1 (da) |
AU (1) | AU702587B2 (da) |
CA (1) | CA2176668C (da) |
DE (1) | DE69605145T2 (da) |
DK (1) | DK0743312T3 (da) |
ES (1) | ES2142030T3 (da) |
FR (1) | FR2734265B1 (da) |
GR (1) | GR3032171T3 (da) |
NO (1) | NO307756B1 (da) |
NZ (1) | NZ286604A (da) |
ZA (1) | ZA963950B (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
AU2003236366A1 (en) * | 2002-04-05 | 2003-10-20 | Sankyo Company, Limited | Oxazolidinone derivatives |
US7205006B2 (en) * | 2003-09-25 | 2007-04-17 | Prime Pharmaceutical Corporation | Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
US20070275990A1 (en) * | 2003-11-13 | 2007-11-29 | Ono Pharmaceutical Co., Ltd. | Heterocyclic Spiro Compound |
EP1758580A4 (en) | 2004-06-24 | 2008-01-16 | Incyte Corp | N-SUBSTITUTED PIPERIDINE AND ITS USE AS A MEDICAMENT |
NZ551602A (en) * | 2004-06-24 | 2010-11-26 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
US7687665B2 (en) | 2004-06-24 | 2010-03-30 | Incyte Corporation | 2-methylprop anamides and their use as pharmaceuticals |
NZ554906A (en) * | 2004-11-10 | 2011-01-28 | Incyte Corp | Lactam compounds and their use as pharmaceuticals |
US8110581B2 (en) | 2004-11-10 | 2012-02-07 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
EP1943250A1 (en) * | 2005-09-09 | 2008-07-16 | Euro-Celtique S.A. | Fused and spirocycle compounds and the use thereof |
CL2008001839A1 (es) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
GB201416352D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
GB201416346D0 (en) * | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
GB201416351D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
MX2018008644A (es) | 2016-01-13 | 2018-11-19 | Gruenenthal Gmbh | Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano. |
AU2017206908B2 (en) | 2016-01-13 | 2020-07-09 | Grünenthal GmbH | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
BR112018014302B1 (pt) | 2016-01-13 | 2023-10-17 | Grünenthal GmbH | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano |
EA034898B1 (ru) | 2016-01-13 | 2020-04-03 | Грюненталь Гмбх | Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана |
TWI640514B (zh) | 2016-01-13 | 2018-11-11 | 歌林達有限公司 | 3-(羧甲基)-8-胺基-2-側氧基-1,3-二氮-螺-[4.5]-癸烷衍生物 |
KR20210123321A (ko) * | 2019-01-11 | 2021-10-13 | 내기스 파마슈티컬스 인코포레이티드 | 류코트리엔 합성 억제제 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL127065C (da) * | 1964-04-22 | |||
FR2666583B1 (fr) * | 1990-09-06 | 1994-09-09 | Adir | Nouveaux derives du spiro [4.5] decane, leur procede de preparation et leurs compositions pharmaceutiques les renfermant. |
WO1997000872A1 (en) * | 1995-06-23 | 1997-01-09 | F.Hoffmann-La Roche Ag | 1,3,8-triaza- and 3,8-diaza-1-oxaspiro(4,5)decane derivatives |
-
1995
- 1995-05-17 FR FR9505833A patent/FR2734265B1/fr not_active Expired - Lifetime
-
1996
- 1996-05-13 DK DK96401029T patent/DK0743312T3/da active
- 1996-05-13 ES ES96401029T patent/ES2142030T3/es not_active Expired - Lifetime
- 1996-05-13 EP EP96401029A patent/EP0743312B1/fr not_active Expired - Lifetime
- 1996-05-13 DE DE69605145T patent/DE69605145T2/de not_active Expired - Fee Related
- 1996-05-13 AT AT96401029T patent/ATE186729T1/de not_active IP Right Cessation
- 1996-05-15 CA CA002176668A patent/CA2176668C/fr not_active Expired - Fee Related
- 1996-05-15 JP JP8120277A patent/JPH08311067A/ja active Pending
- 1996-05-15 AU AU52293/96A patent/AU702587B2/en not_active Ceased
- 1996-05-16 NZ NZ286604A patent/NZ286604A/en unknown
- 1996-05-16 US US08/649,020 patent/US5698567A/en not_active Expired - Fee Related
- 1996-05-17 ZA ZA963950A patent/ZA963950B/xx unknown
- 1996-05-17 CN CN96100292A patent/CN1058014C/zh not_active Expired - Fee Related
- 1996-05-20 NO NO962043A patent/NO307756B1/no not_active IP Right Cessation
-
1999
- 1999-12-17 GR GR990403257T patent/GR3032171T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2176668A1 (fr) | 1996-11-18 |
AU702587B2 (en) | 1999-02-25 |
EP0743312B1 (fr) | 1999-11-17 |
ES2142030T3 (es) | 2000-04-01 |
CA2176668C (fr) | 2001-11-20 |
NO962043D0 (no) | 1996-05-20 |
CN1058014C (zh) | 2000-11-01 |
EP0743312A1 (fr) | 1996-11-20 |
FR2734265B1 (fr) | 1997-06-13 |
JPH08311067A (ja) | 1996-11-26 |
AU5229396A (en) | 1996-11-28 |
DE69605145T2 (de) | 2000-08-17 |
NO962043L (no) | 1996-11-18 |
GR3032171T3 (en) | 2000-04-27 |
NO307756B1 (no) | 2000-05-22 |
DE69605145D1 (de) | 1999-12-23 |
CN1136568A (zh) | 1996-11-27 |
US5698567A (en) | 1997-12-16 |
DK0743312T3 (da) | 2000-05-22 |
ATE186729T1 (de) | 1999-12-15 |
FR2734265A1 (fr) | 1996-11-22 |
NZ286604A (en) | 1998-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA963950B (en) | Heterocyclic spiro compounds, process for the preparation thereof, and pharmaceutical compositions containing them | |
AU1328088A (en) | Herbicidal compounds | |
IL107426A0 (en) | Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
IL104573A0 (en) | Azaindoles,their preparation and pharmaceutical compositions containing them | |
AU6801090A (en) | Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same | |
NZ231062A (en) | ((1,2 benzisoxazol-3-yl)piperidinyl alkyl)-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimdin-4-one derivatives and antipsychotic compositions | |
HUT66515A (en) | Process for preparing piperidine derivatives and pharmaceutical compositions contg. them as active ingredients | |
ATE144983T1 (de) | Neue tricyclische verbindung oder salze davon, verfahren zur herstellung und antimikrobieller wirkstoff, der sie enthält | |
AU4872793A (en) | New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them | |
IL101033A0 (en) | 5-(substituted amino)-1,2,4-triazolo(1,5-a)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
HUT55601A (en) | Fungicide compositions containing oxethane derivatives as active components and process for producing the active components | |
HUT61544A (en) | Heterocyclic compounds | |
IL91756A0 (en) | Pyridoindole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
DE68900990D1 (en) | Thioformamid-derivate. | |
ES8605269A1 (es) | Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central | |
ZA896741B (en) | 3-piperidinyl-indazole derivatives | |
AU4209693A (en) | Novel piperidine derivatives and process for preparation thereof | |
HUT53487A (en) | Fungicide compositions containing nitrogen-containing heterocyclic compounds as active components and process for producing the active components | |
HUT53367A (en) | Process for producing new 1,8-benzonaphtiridine derivatives and pharmaceutical compositions containing them |